IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer

Clinical trial NCT07674615 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07674615
Sponsor: Shanghai Gynecologic Oncology Group
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancers Primary Primary Peritoneal Carcinoma

Start date: 2026-07-01
Primary completion: 2027-06-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.